Michael S. Weiss - 18 Mar 2026 Form 4 Insider Report for Fortress Biotech, Inc. (FBIO)

Role
Executive Vice Chairman, Director
Signature
/s/ Samuel Berry, Attorney-in-Fact
Issuer symbol
FBIO
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
4
Filing time
20 Mar 2026, 16:05:10 UTC
Previous filing
09 Jan 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Michael S. Weiss filed Form 4 for Fortress Biotech, Inc. (FBIO) on 20 Mar 2026."

Quick Takeaways

  • This page summarizes Michael S. Weiss's Form 4 filing for Fortress Biotech, Inc. (FBIO).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 20 Mar 2026, 16:05.

What Changed

  • Previous filing in this sequence was filed on 09 Jan 2026.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
WEISS MICHAEL S Executive Vice Chairman, Director C/O FORTRESS BIOTECH, INC., 1111 KANE CONCOURSE SUITE 301, BAY HARBOR ISLANDS /s/ Samuel Berry, Attorney-in-Fact 20 Mar 2026 0001038977

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FBIO common stock, par value $0.001 Award +475,424 +26% $0.000000* 2,276,562 18 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted 475,424 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on March 18, 2026.

Sponsored